Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA vs UNJHA FORMUL - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL PHARMA UNJHA FORMUL PIRAMAL PHARMA/
UNJHA FORMUL
 
P/E (TTM) x -1,604.7 15.3 - View Chart
P/BV x 4.1 4.5 92.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PIRAMAL PHARMA   UNJHA FORMUL
EQUITY SHARE DATA
    PIRAMAL PHARMA
Mar-24
UNJHA FORMUL
Mar-24
PIRAMAL PHARMA/
UNJHA FORMUL
5-Yr Chart
Click to enlarge
High Rs14925 599.1%   
Low Rs6911 651.7%   
Sales per share (Unadj.) Rs61.841.3 149.6%  
Earnings per share (Unadj.) Rs0.10.6 21.7%  
Cash flow per share (Unadj.) Rs5.70.8 715.4%  
Dividends per share (Unadj.) Rs0.110-  
Avg Dividend yield %0.10-  
Book value per share (Unadj.) Rs59.66.1 977.6%  
Shares outstanding (eoy) m1,322.954.48 29,530.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.80.4 410.9%   
Avg P/E ratio x808.328.5 2,831.8%  
P/CF ratio (eoy) x19.022.1 85.9%  
Price / Book Value ratio x1.82.9 62.9%  
Dividend payout %81.70-   
Avg Mkt Cap Rs m144,03679 181,519.8%   
No. of employees `000NANA-   
Total wages/salary Rs m20,2956 343,983.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,712185 44,178.0%  
Other income Rs m2,0110 1,676,166.7%   
Total revenues Rs m83,723185 45,236.1%   
Gross profit Rs m11,6726 202,640.6%  
Depreciation Rs m7,4061 914,284.0%   
Interest Rs m4,4851 830,537.0%   
Profit before tax Rs m1,7935 39,665.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6152 92,798.9%   
Profit after tax Rs m1783 6,410.1%  
Gross profit margin %14.33.1 458.9%  
Effective tax rate %90.138.5 234.1%   
Net profit margin %0.21.5 14.5%  
BALANCE SHEET DATA
Current assets Rs m55,52338 145,652.4%   
Current liabilities Rs m44,57122 202,964.5%   
Net working cap to sales %13.48.7 153.4%  
Current ratio x1.21.7 71.8%  
Inventory Days Days350-  
Debtors Days Days10318 3.0%  
Net fixed assets Rs m97,45011 869,310.4%   
Share capital Rs m13,23045 29,523.5%   
"Free" reserves Rs m65,610-17 -375,125.8%   
Net worth Rs m78,83927 288,681.8%   
Long term debt Rs m24,8380-   
Total assets Rs m152,97249 310,100.1%  
Interest coverage x1.49.4 14.9%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.53.7 14.2%   
Return on assets %3.06.7 45.3%  
Return on equity %0.210.2 2.2%  
Return on capital %6.118.5 32.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m26,85139 68,812.4%   
Fx outflow Rs m9,5600-   
Net fx Rs m17,29139 44,311.9%   
CASH FLOW
From Operations Rs m10,04510 97,908.4%  
From Investments Rs m-4,340-1 405,616.8%  
From Financial Activity Rs m-4,224-1 782,148.1%  
Net Cashflow Rs m1,6609 19,186.1%  

Share Holding

Indian Promoters % 35.0 36.9 94.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 45.5 0.0 -  
FIIs % 31.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.1 63.1 103.1%  
Shareholders   359,751 3,969 9,064.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on PIRAMAL PHARMA vs UNJHA FORMUL

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PIRAMAL PHARMA vs UNJHA FORMUL Share Price Performance

Period PIRAMAL PHARMA UNJHA FORMUL S&P BSE HEALTHCARE
1-Day -1.93% -2.28% 0.11%
1-Month 7.85% -7.46% -3.22%
1-Year 105.04% 58.75% 42.65%
3-Year CAGR 8.65% 43.62% 19.86%
5-Year CAGR 5.10% 27.44% 25.90%

* Compound Annual Growth Rate

Here are more details on the PIRAMAL PHARMA share price and the UNJHA FORMUL share price.

Moving on to shareholding structures...

The promoters of PIRAMAL PHARMA hold a 35.0% stake in the company. In case of UNJHA FORMUL the stake stands at 36.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PIRAMAL PHARMA and the shareholding pattern of UNJHA FORMUL.

Finally, a word on dividends...

In the most recent financial year, PIRAMAL PHARMA paid a dividend of Rs 0.1 per share. This amounted to a Dividend Payout ratio of 81.7%.

UNJHA FORMUL paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of PIRAMAL PHARMA, and the dividend history of UNJHA FORMUL.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today Indian Rupee at Record Low | Belrise Industries IPO | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.